Avenue Therapeutics, Inc. announced it raised $200,000 in an initial filing from an offering of $5 Million
Avenue Therapeutics, Inc. announced it raised $200,000 in an initial filing from an offering of $5 Million
01/12/17, 4:07 PM
Location
san diegoMoney raised
$200,000
Industry
biotechnology
Round Type
pre-seed
Company Info
Location
9171 towne centre drive, suite 380
san diego, california, united states
Additional Info
Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients. The company’s lead drug candidate, AVZO-021, is a novel, highly potent and selective inhibitor of CDK2, a key enzyme involved in cell cycle regulation. AVZO-021 is being studied in a Phase 1 study in the U.S. for the treatment of advanced solid tumors. Avenzo is headquartered in San Diego, California.